Publication | Closed Access

A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model

Hyperstimulated Rat ModelPituitary GlandGrowth HormoneEndocrine MechanismHuman GrowthPhysiologyVasopressin-induced Vegf SecretionPotential Novel StrategyGynecologyEndocrinologyMedicineOvarian HormoneReproductive Endocrinology